Derfuss T - Search Results

1

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.

Disanto G, Benkert P, Lorscheider J, Mueller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue EW, Sprenger T, Stippich C, Derfuss T, Louvion JF, Kamm CP, Mattle HP, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive PH, Yaldizli Ö, Gobbi C, Kappos L, Kuhle J; SMSC Scientific Board. Disanto G, et al. Among authors: derfuss t. PLoS One. 2016 Mar 31;11(3):e0152347. doi: 10.1371/journal.pone.0152347. eCollection 2016. PLoS One. 2016. PMID: 27032105 Free PMC article.

2

Fingolimod for multiple sclerosis: mechanism of action, clinical outcomes, and future directions.

Mehling M, Kappos L, Derfuss T. Mehling M, et al. Among authors: derfuss t. Curr Neurol Neurosci Rep. 2011 Oct;11(5):492-7. doi: 10.1007/s11910-011-0216-9. Curr Neurol Neurosci Rep. 2011. PMID: 21789537 Review.

3

Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.

Kuhle J, Gosert R, Bühler R, Derfuss T, Sutter R, Yaldizli O, Radue EW, Ryschkewitsch C, Major EO, Kappos L, Frank S, Hirsch HH. Kuhle J, et al. Among authors: derfuss t. Neurology. 2011 Dec 6;77(23):2010-6. doi: 10.1212/WNL.0b013e31823b9b27. Epub 2011 Nov 9. Neurology. 2011. PMID: 22076540 Free PMC article.

4

Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.

Weier K, Beck A, Magon S, Amann M, Naegelin Y, Penner IK, Thürling M, Aurich V, Derfuss T, Radue EW, Stippich C, Kappos L, Timmann D, Sprenger T. Weier K, et al. Among authors: derfuss t. J Neurol. 2012 Dec;259(12):2673-80. doi: 10.1007/s00415-012-6569-4. Epub 2012 Jun 19. J Neurol. 2012. PMID: 22711160

5

Evaluating the potential benefit of interferon treatment in multiple sclerosis.

Derfuss T, Kappos L. Derfuss T, et al. JAMA. 2012 Jul 18;308(3):290-1. doi: 10.1001/jama.2012.8327. JAMA. 2012. PMID: 22797647 No abstract available.

6

Predicting PML in natalizumab-treated patients: can we do better?

Derfuss T, Kappos L. Derfuss T, et al. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1182-3. doi: 10.1136/jnnp-2012-304777. Epub 2013 Apr 20. J Neurol Neurosurg Psychiatry. 2013. PMID: 23606737 No abstract available.

7

T-cell response against varicella-zoster virus in fingolimod-treated MS patients.

Ricklin ME, Lorscheider J, Waschbisch A, Paroz C, Mehta SK, Pierson DL, Kuhle J, Fischer-Barnicol B, Sprenger T, Lindberg RL, Kappos L, Derfuss T. Ricklin ME, et al. Among authors: derfuss t. Neurology. 2013 Jul 9;81(2):174-81. doi: 10.1212/WNL.0b013e31829a3311. Epub 2013 May 22. Neurology. 2013. PMID: 23700335

8

Natalizumab therapy for multiple sclerosis.

Derfuss T, Kuhle J, Lindberg R, Kappos L. Derfuss T, et al. Semin Neurol. 2013 Feb;33(1):26-36. doi: 10.1055/s-0033-1343793. Epub 2013 May 25. Semin Neurol. 2013. PMID: 23709210 Review.

9

Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.

Kuhle J, Malmeström C, Axelsson M, Plattner K, Yaldizli O, Derfuss T, Giovannoni G, Kappos L, Lycke J. Kuhle J, et al. Among authors: derfuss t. Acta Neurol Scand. 2013 Dec;128(6):e33-6. doi: 10.1111/ane.12151. Epub 2013 Jun 13. Acta Neurol Scand. 2013. PMID: 23763388

10

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.

Weier K, Penner IK, Magon S, Amann M, Naegelin Y, Andelova M, Derfuss T, Stippich C, Radue EW, Kappos L, Sprenger T. Weier K, et al. Among authors: derfuss t. PLoS One. 2014 Jan 22;9(1):e86916. doi: 10.1371/journal.pone.0086916. eCollection 2014. PLoS One. 2014. PMID: 24466290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page